Liminatus Pharma, Inc. (LIMN) earnings
Quarterly results of Liminatus Pharma, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Liminatus Pharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Liminatus Pharma, Inc. reported revenue of - and a net loss of $1.4M.
Diluted earnings per share were -$0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$1.4M | -$0.03 |
| Q1 FY2026 | - | - | -$1.1M | -$0.03 |
| Q4 FY2025 | - | - | -$8.2M | - |
| Q3 FY2025 | - | - | -$1.8M | -$0.07 |
| Q2 FY2025 | - | - | $113.3K | $0.00 |
| Q1 FY2025 | - | - | -$327.5K | -$0.02 |
| Q4 FY2025 | - | - | -$229.8K | - |
| Q3 FY2025 | - | - | -$601.4K | -$0.03 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Liminatus Pharma, Inc.'s next earnings date?
Liminatus Pharma, Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.
Get an email when LIMN reports
Follow LIMN and we email you its next results the day they are filed, with the numbers explained.